Trial intelligence / Profile preview

Raltegravir Switch in Stable HIV Patients

NCT01679964Phase 4Completed

Start
Jul 2012
Primary completion
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV). Started Jul 2012; status: completed.

02

Drugs

raltegravir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01679964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01679964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call